Onyx Pharmaceuticals, Inc. [South San Francisco / United States of America]

Onyx Pharmaceuticals, Inc. [South San Francisco / United States of America] located in SOUTH SAN FRANCISCO CALIFORNIA, United States of America under the [Amgen] organization had its last known inspection on 22 Oct 2002. There are 1 known inspections on record.

Site Details

Industries:
Biologics, Human Drugs
Tags:
Biologics, Sponsor
Parent Organization:
Amgen
Last Inspection Date:
22 Oct 2002
FEI:
1000599778
Redica ID:
100164934
Investigators:
Maida Henesian (NMI), Carl Lee, Joseph P Iser, MD

Onyx Pharmaceuticals, Inc. [South San Francisco / United States of America]'s Most Recent Documents

Publish Date Document Type Title
October, 2002 EIR Onyx Pharmaceuticals, Inc. - EIR, 2002-10-22
October, 2002 FDA 483 Onyx Pharmaceuticals, Inc. - Form 483, 2002-10-22

Experience Redica Systems’ NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Site Profile Icon

Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more